Telix Pharmaceuticals TLX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$222.3K (8 inflow days, 12 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 35.1% of shares outstanding.
Largest holders
By investor type
Reported short interest has held roughly steady near 0.08% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +1,137,118 | 0.8% |
| BetaShares Capital Limited | Mutual Fund | 2026/Q3 | +149,259 | 0.6% |
| JPMorgan Chase & Co. | Public Company | 2026/Q3 | +4,167,050 | 9.0% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +950,408 | 0.8% |
| William Blair Investment Management, LLC | Mutual Fund | 2026/Q3 | +357,700 | 0.1% |
| Vanguard Investments Australia Limited | Mutual Fund | 2026/Q3 | +188,531 | 1.9% |
| Vanguard Asset Management, Limited | Mutual Fund | 2026/Q3 | +180,887 | 0.3% |
| BetaShares Capital Limited | Mutual Fund | 2026/Q3 | +123,546 | 0.6% |
| Aubrey Capital Management Limited | Mutual Fund | 2026/Q3 | +105,000 | 0.0% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +100,696 | 3.1% |
| Hennion & Walsh Asset Management, Inc. | Mutual Fund | 2026/Q3 | +65,718 | 0.1% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +871,964 | 0.8% |
| Vanguard Asset Management, Limited | Mutual Fund | 2026/Q3 | +66,893 | 0.2% |
| Van Eck Associates Corporation | Mutual Fund | 2026/Q3 | +49,637 | 0.2% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +47,292 | 3.1% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 6 Sep 2026 | Darren Smith | Group Chief Financial Officer | Private Acquisition | +2,071 | $9.66 | 13,992 |
| 28 Apr 2026 | Christian Behrenbruch | Co-Founder, MD, Group CEO & Executive Director | Open Market Acquisition | +67,935 | $14.87 | 20,996,941 |
| 28 Mar 2026 | Darren Smith | Group Chief Financial Officer | Derivative Exercise and Retained | +1,111 | – | 11,921 |
| 17 Mar 2026 | David Cade | Group Chief Medical Officer | Initial Statement of Beneficial | +0 | – | 12,566 |
| 17 Mar 2026 | Darren Smith | Group Chief Financial Officer | Initial Statement of Beneficial | +0 | – | 15,852 |
| 17 Mar 2026 | Mark Nelson | Independent Non-Executive Director | Initial Statement of Beneficial | +0 | – | 3,628,750 |
| 17 Mar 2026 | Christian Behrenbruch | Co-Founder, MD, Group CEO & Executive Director | Initial Statement of Beneficial | +0 | – | 2,595 |
| 17 Mar 2026 | Jann Skinner | Independent Non-Executive Director | Initial Statement of Beneficial | +0 | – | 595,000 |
| 17 Mar 2026 | Darren Patti | Group Chief Operating Officer | Initial Statement of Beneficial | +0 | – | 804 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 270,623 | 0.1% | 1.0 |
| 15 Oct 2026 | 352,936 | 0.1% | 1.1 |
| 30 Sep 2026 | 426,829 | 0.1% | 1.0 |
| 15 Sep 2026 | 352,524 | 0.1% | 1.0 |
| 31 Aug 2026 | 264,943 | 0.1% | 1.8 |
| 14 Aug 2026 | 244,900 | 0.1% | 2.3 |
No comments yet — be the first to weigh in on TLX.
Sign in to join the discussion.